Although NSUN2 levels were upregulated in both ovarian and cervical cancers, knockdown of NSUN2 did not reduce aggressive phenotypes of ovarian cancer cells, suggesting that upregulation of NSUN2 is likely an accompanied effect but not a fundamental driving force in ovarian cancer. Here, NSUN2 is linked to ovarian carcinoma.